Antiproliferative agent-26 (compound 4g) exhibits a broad spectrum of activity against leukemia, CNS cancers, melanoma, renal, and breast cancers at a concentration of 10 μM. It hinders colony formation and induces cell cycle arrest in the G1 phase at 5 μM, while arresting the cell cycle at the S phase at 25 μM [1].